DIA’s chief exec is on a mission to grow its footprint across healthcare

Marwan Fathallah came onboard earlier this year to lead the organization into an era of change.

By Michael Gibney • June 22, 2023

10 years proud: Pharma’s top companies for LGBTQ+ inclusivity

These six Big Pharma companies have ranked among the best places to work for LGTBQ+ equality by the Human Rights Campaign Foundation for over 10 years. Here’s why. 

By Karissa Waddick , Taren Grom • June 22, 2023

Explore the Trendline➔

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

By PharmaVoice staff

Duty to serve: an Army officer’s unexpected path to GSK

How Court Horncastle, SVP, business unit head of the anti-infective and respiratory team at GSK, applies lessons from combat to his work in antibiotics.

By Alexandra Pecci • June 21, 2023

Woman of the Week: Stealth BioTherapeutics’ Reenie McCarthy

How the CEO navigated a regulatory odyssey to bring the company’s lead program for an ultra-rare disease to a fast track approval.

By Taren Grom • June 21, 2023

Shaking up pharma: Change that leaders would like to see

Industry execs give voice to the “game changers” they believe would have the greatest impact on the healthcare ecosystem for all.

By Taren Grom • June 16, 2023

Woman of the Week: Gamida Cell’s Abbey Jenkins

The first-time CEO discusses the lessons she has learned since taking the role last year and how she’s pivoting the company into a commercial entity.

By Taren Grom • June 14, 2023

The ingredients of a successful biopharma collaboration

Collaboration is important along the entire spectrum and lifecycle of biopharma, and finding an effective partner is harder than it sounds.

By Michael Gibney • June 13, 2023

Yes, biopharma still has a reputation problem. These leaders are looking for solutions

Negative news is breaking down the public’s perception of the biopharma industry — but leaders around the industry have some ideas to fix it.

By Michael Gibney • June 8, 2023

Woman of the Week: Marinus Pharmaceuticals’ Christy Shafer

The chief commercial officer shares how the company “beat the odds” to bring a rare disease drug to market.

By Taren Grom • June 7, 2023

Ranking reveals biopharma’s most innovative companies

IDEA Pharma’s 12th index finds that Pfizer and AstraZeneca reign supreme again.

By Taren Grom • June 7, 2023

BIO’s CEO digs into the hot-button issues facing the industry

Rachel King took the reins at BIO during a rocky time. Now, after steadying the ship, she’s brought the trade association’s focus back to the industry’s most pressing priorities.

By Alexandra Pecci • June 5, 2023

Janssen and Legend’s longtime collaboration lands a CAR-T win at ASCO

A partnership going on six years between the pharma giant and the Chinese biotech is showing that their CAR-T cell therapy for multiple myeloma is highly effective.

By Michael Gibney • June 5, 2023

A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking

Healthcare pros share the market drivers they believe are having the biggest impact on the industry.

By Taren Grom • June 2, 2023

How Takeda finds the hottest new science to fuel its oncology work

Takeda's president of the global oncology business unit is always "scanning the horizon" for the partnerships that will drive the next big innovations.

By Michael Gibney • June 1, 2023

Woman of the Week: Mirati Therapeutics’ Laurie Stelzer

With the recent approval of Krazati, the biotech veteran is guiding Mirati into its next phase as a commercial organization.

By Taren Grom • May 31, 2023

The ‘superpowers’ pharma leaders should cultivate

Executives honored by the Healthcare Businesswomen’s Association share the key traits that help them drive results.

By Taren Grom • May 26, 2023

Woman of the Week: Cognition Therapeutics’ Lisa Ricciardi

As CEO of the neurogenerative company, Ricciardi is applying her decades of “human capital” to advance Alzheimer’s and dementia treatments.

By Taren Grom • May 24, 2023

How biopharma executives fight burnout

Pharma leaders share what they do to keep their teams from fizzling out.

By Taren Grom • May 19, 2023

What pharma can teach biotech about the life cycle management of a drug

Global product teams are common in pharma but have yet to gain traction in biotech. Here's why this model can work.

By Dr. Stephen Dale and Kathleen Ford • May 18, 2023

Woman of the Week: Genentech’s Veronica Sandoval

How the Genentech diversity exec is using ‘three Ms’ to reduce health disparities and improve access for under-supported communities.

By Taren Grom • May 17, 2023

A day in the life of a pharma exec: Lyndra’s Patricia Hurter

How the CEO starts each day with a ride on one of her horses, reduces daily meetings and uses her network to get through crises like the SVB Bank collapse.

By Meagan Parrish • May 17, 2023

Woman of the Week: Reneo Pharmaceuticals’ Ashley Hall

After ushering a blockbuster to market, the chief development officer is channeling her experience into the rare disease space.

By Taren Grom • May 10, 2023

AbbVie’s Christopher Boone on RWE’s potential — and its ‘profound ethical dilemmas’

With decades of experience in public health, Boone is leveraging RWE to move the needle within clinical development.

By Taren Grom • May 10, 2023

This ‘hot-blooded’ CEO is aiming to transform the way burn victims heal

Cutiss CEO Daniela Marino is funneling her bold personality and expertise in regenerative medicine into a startup developing bioengineered skin grafts.

By Alexandra Pecci • May 9, 2023

How Immunocore’s Bahija Jallal embraced the ‘a-ha’ moment of promising science

The biotech CEO is bullish on the company’s pioneering T cell receptor platform and innovating new immunology-based treatments.

By Taren Grom • May 5, 2023